Literature DB >> 22117997

Oxidative stress levels in myelodysplastic syndrome patients: their relationship to serum ferritin and haemoglobin values.

K Saigo1, M Takenokuchi, Y Hiramatsu, H Tada, T Hishita, M Takata, M Misawa, S Imoto, S Imashuku.   

Abstract

Reactive oxygen species (ROS) and serum ferritin levels are both considered to be important biological factors in the pathogenesis of myelodysplastic syndrome (MDS). This study evaluated the levels of ROS in 40 patients with MDS (19 males and 21 females) using the Free Radical Analytical System, FRAS4, and derivatives of reactive oxygen metabolite kits. The patients' mean age was 67.3 years (range 58 - 86 years). The sera of 34 (85%) patients exhibited higher levels of oxidative stress than the reference range. There was a positive correlation between ROS levels and serum ferritin levels, and a negative correlation between ROS levels and haemoglobin levels. There was a negative relationship between serum haemoglobin and ferritin levels. The results indicated that iron accumulation or severe anaemia could contribute to oxidative stress in MDS patients. Iron chelation and antioxidant therapy may be suitable for the management of MDS.

Entities:  

Mesh:

Substances:

Year:  2011        PMID: 22117997     DOI: 10.1177/147323001103900539

Source DB:  PubMed          Journal:  J Int Med Res        ISSN: 0300-0605            Impact factor:   1.671


  16 in total

Review 1.  Iron overload in myelodysplastic syndromes (MDS).

Authors:  Norbert Gattermann
Journal:  Int J Hematol       Date:  2017-11-25       Impact factor: 2.490

2.  Oxidative stress levels are correlated with P15 and P16 gene promoter methylation in myelodysplastic syndrome patients.

Authors:  Ana Cristina Gonçalves; Emília Cortesão; Barbara Oliveiros; Vera Alves; Ana Isabel Espadana; Luís Rito; Emília Magalhães; Sónia Pereira; Amélia Pereira; José Manuel Nascimento Costa; Luisa Mota-Vieira; Ana Bela Sarmento-Ribeiro
Journal:  Clin Exp Med       Date:  2015-05-17       Impact factor: 3.984

3.  Morphological and flow-cytometric analysis of haemin-induced human neutrophil activation: implications for transfusion-related acute lung injury.

Authors:  Mari Kono; Katsuyasu Saigo; Yuri Takagi; Sawako Kawauchi; Atsushi Wada; Makoto Hashimoto; Takeshi Sugimoto; Mariko Takenokuchi; Takashi Morikawa; Kunihiro Funakoshi
Journal:  Blood Transfus       Date:  2012-06-28       Impact factor: 3.443

4.  HFE gene mutation and oxidative damage biomarkers in patients with myelodysplastic syndromes and its relation to transfusional iron overload: an observational cross-sectional study.

Authors:  Geane Felix De Souza; Howard Lopes Ribeiro; Juliana Cordeiro De Sousa; Fabíola Fernandes Heredia; Rivelilson Mendes De Freitas; Manoel Ricardo Alves Martins; Romélia Pinheiro Gonçalves; Ronald Feitosa Pinheiro; Silvia Maria Meira Magalhães
Journal:  BMJ Open       Date:  2015-04-03       Impact factor: 2.692

5.  Effects of iron overload on the bone marrow microenvironment in mice.

Authors:  Yuchen Zhang; Wenjing Zhai; Mingfeng Zhao; Deguan Li; Xiao Chai; Xiaoli Cao; Juanxia Meng; Jie Chen; Xia Xiao; Qing Li; Juan Mu; Jichun Shen; Aimin Meng
Journal:  PLoS One       Date:  2015-03-16       Impact factor: 3.240

6.  The Simultaneous Elevation of Oxidative Stress Markers and Wilms' Tumor 1 Gene during the Progression of Myelodysplastic Syndrome.

Authors:  Naomi Shimizu; Hidekazu Hasunuma; Yasuhiro Watanabe; Yasuo Matsuzawa; Youichi Iwashita; Ichiro Tatsuno; Hiromitsu Yokota
Journal:  Intern Med       Date:  2016-12-15       Impact factor: 1.271

7.  Labile plasma iron levels predict survival in patients with lower-risk myelodysplastic syndromes.

Authors:  Louise de Swart; Chloé Reiniers; Timothy Bagguley; Corine van Marrewijk; David Bowen; Eva Hellström-Lindberg; Aurelia Tatic; Argiris Symeonidis; Gerwin Huls; Jaroslav Cermak; Arjan A van de Loosdrecht; Hege Garelius; Dominic Culligan; Mac Macheta; Michail Spanoudakis; Panagiotis Panagiotidis; Marta Krejci; Nicole Blijlevens; Saskia Langemeijer; Jackie Droste; Dorine W Swinkels; Alex Smith; Theo de Witte
Journal:  Haematologica       Date:  2017-11-09       Impact factor: 9.941

Review 8.  EnvIRONmental Aspects in Myelodysplastic Syndrome.

Authors:  Verena Petzer; Igor Theurl; Günter Weiss; Dominik Wolf
Journal:  Int J Mol Sci       Date:  2021-05-14       Impact factor: 5.923

9.  Deferasirox reduces oxidative stress in patients with transfusion dependency.

Authors:  Katsuyasu Saigo; Mari Kono; Yuri Takagi; Mariko Takenokuchi; Yasushi Hiramatsu; Hiroshi Tada; Terutoshi Hishita; Masahito Misawa; Shion Imoto; Shinsaku Imashuku
Journal:  J Clin Med Res       Date:  2013-01-11

10.  Plasma levels of aminothiols, nitrite, nitrate, and malondialdehyde in myelodysplastic syndromes in the context of clinical outcomes and as a consequence of iron overload.

Authors:  Kristýna Pimková; Leona Chrastinová; Jiří Suttnar; Jana Štikarová; Roman Kotlín; Jaroslav Čermák; Jan Evangelista Dyr
Journal:  Oxid Med Cell Longev       Date:  2014-01-14       Impact factor: 6.543

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.